Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
Dublin, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/fgjml9/neurostimulation) has announced the addition of the "Neurostimulation - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the worldwide markets for Neurostimulation in US$ by the following Product Segments: Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Sacral Nerve Stimulators (SNS), Vagus Nerve Stimulators (VNS), and Gastric Electric Stimulators (GES).
The United States is analyzed both in terms of value (US$) and volume (units) sales.
The report profiles 30 companies including many key and niche players such as
- Aleva Neurotherapeutics SA (Switzerland)
- BioControl Medical (Israel)
- Bioness Inc. (USA)
- Boston Scientific Corp. (USA)
- EnteroMedics Inc. (USA)
- LivaNova PLC (UK)
- Medtronic, Inc. (USA)
- NeuroPace, Inc. (USA)
- NeuroSigma, Inc. (USA)
- Nevro Corp. (USA)
- SPR Therapeutics, LLC (US)
- St. Jude Medical, Inc. (USA)
- Synapse Biomedical, Inc. (USA)
Key Topics Covered:
1. MARKET OVERVIEW
2. COMPETITIVE SCENARIO
3. GROWTH DRIVERS, TRENDS, & ISSUES
4. MACRO GROWTH DRIVERS FOR NEUROSTIMULATION INDUSTRY
5. TECHNOLOGICAL ADVANCEMENTS IN NEUROSTIMULATION MARKET
6. SELECT TARGETED INDICATIONS
7. PRODUCT OVERVIEW
8. NEUROSTIMULATION DEVICE APPROVALS
9. PRODUCT INNOVATIONS/INTRODUCTIONS
10. RECENT INDUSTRY ACTIVITY
11. FOCUS ON SELECT PLAYERS
12. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 30 (including Divisions/Subsidiaries - 31)
- The United States (23)
- Europe (7)
- - Germany (2)
- - The United Kingdom (2)
- - Rest of Europe (3)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/fgjml9/neurostimulation
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Neurology Devices
